medicine,dosage_calc
abemaciclib,"Abemaciclib is indicated for early, advanced, metastatic breast cancer. The supplied unit was average daily dose (ADD), it is assumed here that 1 daily dose equals 1 ADD.
"
neratinib,"Neratinib is indicated for early breast cancer, the supplied unit was milligrams. Based on the WHO Defined Daily Dose (DDD), 1 daily dose for neratinib is here calculated as 240mg."
palbociclib,"Palbociclib is indicated for locally advanced or metastatic breast cancer. The supplied unit was DDD, here 1 daily dose is calculated as 1 DDD. "
ribociclib,"Ribociclib is indicated for locally advanced or metastatic breast cancer. The supplied unit is tablets, based on the Summary of Product Characteristics (SmPC) we have calculated 1 tablet to equal 200mg. Using the WHO DDD 1 daily dose is here calculated to be 1 DDD (450mg). "
trastuzumab deruxtecan,"Trastuzumab deruxtecan is indicated for unresectable or metastatic breast cancer. The supplied unit is vials, based on the SmPC, 1 vial of powder for concentrate for solution for infusion contains 100 mg of trastuzumab deruxtecan. The posology states the recommended dose is 5.4 mg/kg given as an intravenous infusion once every 3 weeks (21-day cycle) until disease progression or unacceptable toxicity. Here we have used the average body weight of an adult female (72.1kg). For this calculation it is assumed no dose reduction takes place. 1 daily dose = 18.59 mg of trastuzumab deruxtecan."
trastuzumab emtansine,"Trastuzumab emtansine is indicated for early, advanced and metastatic breast cancer. The supplied unit is vials, based on the SmPC, 1 vial of powder for concentrate for solution for infusion contains 100 or 160 mg of trastuzumab emtansine. Here it has been assumed each vial contains 130mg of trastuzumab emtansine. The posology states the recommended dose of trastuzumab emtansine is 3.6 mg/kg bodyweight administered as an intravenous infusion every 3 weeks (21-day cycle). Here we have used the average body weight of an adult female (72.1kg). For this calculation it is assumed no dose reduction takes place. 1 daily dose = 12.39 mg of trastuzumab emtansine. "
tucatinib,"Tucatinib is indicated for locally advanced or metastatic breast cancer. The supplied unit was DDD, here 1 daily dose is calculated as 1 DDD. "
